Results 181 to 190 of about 29,187 (260)

The Market for Monoclonal Antibodies: Trends, Challenges, and Opportunities. [PDF]

open access: yesBioDrugs
Motta-Santos AS   +5 more
europepmc   +1 more source

What We Know and What's Next on Responsible Innovation in Business: A Systematic Review and a Research Agenda

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT Responsible Innovation (RI) has gained increasing attention over the past decade, primarily in the context of publicly funded scientific research. However, in business scholarship, RI remains an emerging and fragmented concept, lacking a consensus on its definition, scope, boundary conditions, and uneven evidence on how firms operationalize RI
Yuyan Wei, Devashish Pujari, Nuree Ha
wiley   +1 more source

Exploring the Effects of Integrated Thinking and Reporting on Corporate Performance: A Multidimensional Analysis

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT This study aims to test the effectiveness of adopting Integrated Thinking and Reporting (ITR) in enhancing distinct but interconnected dimensions of corporate performance, namely, organizations' environmental, social, and financial performance, ultimately addressing their activities towards the achievement of sustainable development.
Maria Cleofe Giorgino   +3 more
wiley   +1 more source

Signalling ESG Misconduct: What Matters to Investors?

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT We investigate what matters most to investors when environmental, social and governance (ESG)‐related corporate misconduct news is signalled and how these factors influence the magnitude of market value punishment. Using an event study on 44,859 corporate news items related to ESG incidents, we find that investors react negatively to such ...
Dewan Muktadir‐Al‐Mukit
wiley   +1 more source

Home - About - Disclaimer - Privacy